2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Refractory/Relapse Neuroblastoma
1
Papillomavirus Infections
1
Osteoporosis
1
Neuroendocrine Tumors
1
Neoplasms, Squamous Cell
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, B-Cell
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Infertility
1
Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma
1
Hodgkin Disease
1
High Grade Cervical Intraepithelial Neoplasia
1
Esophageal Neoplasms
1
Burkitt Lymphoma
1
Interventions
Zoledronic Acid
16
Risedronic Acid
9
Vitamin D
8
Calcium
8
Letrozole
7
Absorptiometry, Photon
6
Cholecalciferol
5
Calcium Carbonate
5
Alendronate
5
Denosumab
4
Calcium Gluconate
3
parathyroid hormone-related peptide (1-36)
2
bicalutamide
2
Resistance Training
2
Progesterone
2
Nutrition Assessment
2
Kyphoplasty
2
Hormone Replacement Therapy
2
Goserelin
2
Estradiol
2
Calcium Citrate
2
Aromatase Inhibitors
2
Anastrozole
2
xian ling gu bao
1
romosozumab
1
X-Rays
1
Toremifene
1
Testosterone
1
Technetium
1
Spectrum Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteoporosis
×
Biological Products
×
Clear all
NCT01250314
2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
79 enrolled